Medicaid

It’s easy for the average American to dismiss the impact of the nation’s opioid abuse epidemic. However, heroin and prescription opioid painkiller addiction may be costing Americans much more than they realize. A recent study by the U.S. Surgeon General found that 27 million Americans...

The poor, the elderly, the disabled, college students and environmental protections all stand to take a big hit if Congress approves President Donald Trump’s $4.1 trillion budget for fiscal year 2018. Defense contractors, corporations in general and the wealthiest Americans all stand to gain...

Few investors consider a 150-year-old company as one that has a pathway toward growth, but there are always exceptions to every rule. Barclays' Joshua Raskin maintains an Overweight rating on the 150-year old diversified healthcare company Aetna Inc (NYSE: AET) with a $162 price target. In a...

Somewhere beyond the cacophony over President Donald Trump’s firing of FBI Director James Comey is a steady, behind-the-scenes hum about healthcare, which won’t stay yesterday’s news for very long. Analysts at Height Securities, LLC say the U.S. Senate has to deal with healthcare...

Republicans have proposed to repeal the Affordable Care Act, colloquially known as "Obamacare," and are seeking approval for the new GOP healthcare bill dubbed Trumpcare. President Donald Trump has proposed significant tax cuts to reduce healthcare expense, with Medicaid expected to bear most of...

Leerink's Global Healthcare Conference kicked off Wednesday and will continue through Thursday. Here is a summary of what Leerink's analysts are saying about some of the notable companies who presented at on Wednesday. Universal Health Services Universal Health Services, Inc. (NYSE: UHS)'s chief...

The Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM) deal hangs in limbo as John Bates, the Federal Judge appointed to oversee the case is yet to give a timeline for the final ruling even after the final hearing is over. The deadline, which has been pushed forward twice, now looms large, with...

We are closing in on Donald Trump's elevation to the highest office in the country, and a range of emotions runs through the minds of different stakeholders as Trump has threatened large-scale policy overhauls. One of policies that Trump is taking potshots at is Patient Protection and Affordable...

With the Republicans in control of Capitol Hill, the outlook for Social Security in its current iteration is uncertain as many party members argue for sweeping reforms to Social Security to reduce government spending. Add to that the unreliability of President-elect Donald Trump's rhetoric...

Donald Trump’s victory and the “Republican sweep of Congress” could have a significantly greater impact on equity values than the initial share price moves, Credit Suisse’s Scott Fidel said in a report. He added that the outlook for the Diversified MCO [Managed Care...

Investor sentiment on Mylan NV (NASDAQ: MYL) shares remain upbeat ahead of the third-quarter results Wednesday after the market closes. The biotech stock and peers within the space gained after Hillary Clinton lostthe presidential election. Past Performance In the first two quarters of the current...

KeyBanc analysts believe Magellan Health Inc (NASDAQ: MGLN)'s dearth of experience in handling Medicaid populations will likely take away from the company's ability to win state procurement from more seasoned competitors. Thus, the bank initiated coverage on Magellan Thursday with a Sector Weight...

Citi started coverage of Cotiviti Holdings Inc (NYSE: COTV) with a Neutral rating and $21 price target, citing near-term risks including client M&A among its relatively concentrated customer base. "Net, we have a favorable view of the company's offerings but with an ETR of ~10%,...

Aetna Inc (NYSE: AET) came out with better-than-expected first-quarter results on Tuesday. Operating EPS for the company came at $2.39 on revenue of $51.1 billion, versus analysts' expectations of $1.95 and $15.5 billion respectively. Ana Gupte from Leerink Partners, was on CNBC following the...

As the U.S. works to completely overhaul its healthcare system, lawmakers are looking at the cost of prescription medications for a way to cut back on spending. DRX, a firm that compares healthcare options, found that between 2007 and 2014 drugs used for a variety of conditions saw price hikes...